Search clinical trials for: P53 wild type
Total 64345 results
-
Gustave Roussy, Cancer Campus, Grand ParisCompletedLymphomaFrance, Spain, Italy, Belgium, Germany, Switzerland, Austria, United Kingdom, Netherlands, Sweden
-
Seoul National University HospitalCompletedGastroesophageal Reflux DiseaseKorea, Republic of
-
Novartis PharmaceuticalsCompletedSolid Tumor With p53 Wild Type StatusFrance, Germany, Singapore, Switzerland, United States
-
Moy-Fincher-Chipps Facial Plastics and DermatologyUnknown
-
Rambam Health Care CampusCompletedSerous Papillary Endometrial CancerIsrael
-
Shenzhen SiBiono GeneTech Co.,LtdUnknownAdvanced Oral and Maxillofacial Malignant TumorsChina
-
National Cancer Institute (NCI)CompletedRecurrent Bladder Cancer | Stage III Bladder Cancer | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Stage I Bladder Cancer | Stage II Bladder CancerUnited States
-
Shenzhen SiBiono GeneTech Co.,LtdUnknownHCC | DiabetesChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Department of Health and Human ServicesTerminated
-
Shenzhen SiBiono GeneTech Co.,LtdUnknownAdvanced Hepatocellular Carcinoma (HCC)China
-
Shenzhen SiBiono GeneTech Co.,LtdUnknown
-
Shanghai Changzheng HospitalUnknownRefractory Cancer | Arsenic Trioxide | p53 Mutations | Intractable CancerChina
-
Ruijin HospitalRecruitingP53 Mutation | Myeloid Malignancy | MDS | AmlChina
-
University of Texas Southwestern Medical CenterNational Cancer Institute (NCI)CompletedOvarian Cancer | Peritoneal Cavity CancerUnited States
-
French Innovative Leukemia OrganisationJanssen, LPActive, not recruitingRelapsed or Refractory Chronic Lymphocytic LeukemiaFrance
-
National Cancer Institute (NCI)CompletedLip and Oral Cavity Cancer | Oropharyngeal Cancer | Tongue Cancer | Stage 0 Lip and Oral Cavity Cancer | Stage 0 Oropharyngeal CancerUnited States
-
Affiliated Hospital of Jiangnan UniversityCompleted
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedLung CancerUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States
-
Sohag UniversityNot yet recruitingInvasive Breast Cancer
-
Aventis PharmaceuticalsUnknownHead and Neck CancerUnited States
-
National Cancer Institute (NCI)Completed
-
Joaquina BarandaActive, not recruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Cancer | Solid Tumor | Malignant Disease | Relapsed Hematologic MalignancyUnited States
-
Shenzhen SiBiono GeneTech Co.,LtdUnknown
-
Federal University of São PauloCompletedPhotoaging | Epidermal p53 ExpressionBrazil
-
National Cancer Institute (NCI)CompletedBrain and Central Nervous System Tumors
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Platinum-Resistant Ovarian Carcinoma | Recurrent Platinum-Resistant Fallopian Tube Carcinoma | Recurrent Platinum-Resistant Primary Peritoneal CarcinomaUnited States
-
Shenzhen SiBiono GeneTech Co.,LtdUnknownAdvanced Head and Neck CancerChina
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedLung CancerUnited States
-
Merck Sharp & Dohme LLCCompletedOvarian Cancer | Fallopian Tube Cancer | Metastatic Cancer | Primary Peritoneal Cavity Cancer
-
University Medical Center GroningenISA Pharmaceuticals B.V.; Dutch Cancer SocietyCompletedOvarian CancerNetherlands
-
University of Michigan Rogel Cancer CenterAscentage Pharma Group Inc.SuspendedSalivary Gland Cancer | Malignant Salivary Gland CancerUnited States
-
PMV Pharmaceuticals, IncActive, not recruitingHealthy VolunteersUnited States
-
Leiden University Medical CenterUniversity Medical Center GroningenCompletedRecurrent Ovarian CancerNetherlands
-
Li JunminUnknownAcute Myeloid Leukemia | P53 MutationChina
-
Sunnybrook Health Sciences CentreNovartisCompleted
-
Assiut UniversityCompleted
-
Centre Leon BerardNovartis; National Cancer Institute, FranceRecruitingAdvanced Soft-tissue Sarcoma | Metastatic Soft-tissue SarcomaFrance
-
Rain Oncology IncWithdrawnMilademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A LossMelanoma | Renal Cell Carcinoma | Gastric Cancer | NSCLC | Mesothelioma | Advanced Solid Tumor | Pancreas Adenocarcinoma | Urothelial Carcinoma Bladder | HNSCC | CDKN2A
-
First Affiliated Hospital of Jinan UniversityRuijin HospitalRecruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | P53 Mutation | Myeloid Malignancy | Temperature-Sensitive p53 Mutation | Sodium StibogluconateChina
-
National Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)Terminated
-
Shenzhen SiBiono GeneTech Co.,LtdUnknownOvarian Epithelial Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerChina
-
Hossam Hassan Aly Hassan El SokkaryCompleted
-
Haukeland University HospitalTerminatedColorectal Cancer Metastatic | Colorectal Cancer Stage IV | TP53 Gene MutationNorway
-
National Cancer Institute (NCI)Terminated
-
Altor BioScienceNational Cancer Institute (NCI)CompletedMetastatic MelanomaUnited States
-
Shenzhen SiBiono GeneTech Co.,LtdUnknownNon-small Cell Lung CancerChina
-
The First Affiliated Hospital of Xiamen UniversityShanxi Province Cancer Hospital; Sun Yat-sen University; Jiangsu Provincial People... and other collaboratorsRecruiting